211 related articles for article (PubMed ID: 23389951)
1. MiR-10a* up-regulates coxsackievirus B3 biosynthesis by targeting the 3D-coding sequence.
Tong L; Lin L; Wu S; Guo Z; Wang T; Qin Y; Wang R; Zhong X; Wu X; Wang Y; Luan T; Wang Q; Li Y; Chen X; Zhang F; Zhao W; Zhong Z
Nucleic Acids Res; 2013 Apr; 41(6):3760-71. PubMed ID: 23389951
[TBL] [Abstract][Full Text] [Related]
2. MiR-342-5p suppresses coxsackievirus B3 biosynthesis by targeting the 2C-coding region.
Wang L; Qin Y; Tong L; Wu S; Wang Q; Jiao Q; Guo Z; Lin L; Wang R; Zhao W; Zhong Z
Antiviral Res; 2012 Feb; 93(2):270-279. PubMed ID: 22197249
[TBL] [Abstract][Full Text] [Related]
3. Cardiac miR-19a/19b was induced and hijacked by CVB3 to facilitate virus replication via targeting viral genomic RdRp-encoding region.
Wu Y; Yue Y; Xiong S
Antiviral Res; 2023 Sep; 217():105702. PubMed ID: 37604350
[TBL] [Abstract][Full Text] [Related]
4. Coxsackievirus B3 engineered to contain microRNA targets for muscle-specific microRNAs displays attenuated cardiotropic virulence in mice.
He F; Yao H; Wang J; Xiao Z; Xin L; Liu Z; Ma X; Sun J; Jin Q; Liu Z
J Virol; 2015 Jan; 89(2):908-16. PubMed ID: 25339771
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-22-3p displaces critical host factors from the 5' UTR and inhibits the translation of Coxsackievirus B3 RNA.
Rani P; George B; V S; Biswas S; V M; Pal A; Rajmani RS; Das S
J Virol; 2024 Feb; 98(2):e0150423. PubMed ID: 38289119
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-203 enhances coxsackievirus B3 replication through targeting zinc finger protein-148.
Hemida MG; Ye X; Zhang HM; Hanson PJ; Liu Z; McManus BM; Yang D
Cell Mol Life Sci; 2013 Jan; 70(2):277-91. PubMed ID: 22842794
[TBL] [Abstract][Full Text] [Related]
7. Expression of an antigenic adenovirus epitope in a group B coxsackievirus.
Höfling K; Tracy S; Chapman N; Kim KS; Smith Leser J
J Virol; 2000 May; 74(10):4570-8. PubMed ID: 10775593
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
9. [The suppressive effect of MiR-490 on coxsackievirus B3 replication].
Wang LL; Zhong ZH; Wang Q; Lu P; Li M; Xu HY
Bing Du Xue Bao; 2014 Nov; 30(6):619-23. PubMed ID: 25868275
[TBL] [Abstract][Full Text] [Related]
10. Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.
Smithee S; Tracy S; Chapman NM
J Virol; 2015 Dec; 89(23):11761-72. PubMed ID: 26355088
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circ_0076631 promotes coxsackievirus B3 infection through modulating viral translation by sponging miR-214-3p.
Qin Y; Lin L; Yang S; Dai Z; Zhang C; Huang J; Deng F; Yue X; Ren L; Fei Y; Zhao W; Wang Y; Zhong Z
Front Microbiol; 2022; 13():975223. PubMed ID: 36147837
[TBL] [Abstract][Full Text] [Related]
12. Engineered coxsackievirus B3 containing multiple organ-specific miRNA targets showed attenuated viral tropism and protective immunity.
Xiao Z; He F; Feng M; Liu Z; Liu Z; Li S; Wang W; Yao H; Wu J
Infect Genet Evol; 2022 Sep; 103():105316. PubMed ID: 35718333
[TBL] [Abstract][Full Text] [Related]
13. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
14. Secondary heterotypic versus homotypic infection by Coxsackie B group viruses: impact on early and late histopathological lesions and virus genome prominence.
Yu JZ; Wilson JE; Wood SM; Kandolf R; Klingel K; Yang D; McManus BM
Cardiovasc Pathol; 1999; 8(2):93-102. PubMed ID: 10724506
[TBL] [Abstract][Full Text] [Related]
15. Functional Consequences of RNA 5'-Terminal Deletions on Coxsackievirus B3 RNA Replication and Ribonucleoprotein Complex Formation.
Lévêque N; Garcia M; Bouin A; Nguyen JHC; Tran GP; Andreoletti L; Semler BL
J Virol; 2017 Aug; 91(16):. PubMed ID: 28539455
[TBL] [Abstract][Full Text] [Related]
16. Coxsackievirus B3 Induces Autophagic Response in Cardiac Myocytes in vivo.
Zhai X; Bai B; Yu B; Wang T; Wang H; Wang Y; Li H; Tong L; Wang Y; Zhang F; Zhao W; Zhong Z
Biochemistry (Mosc); 2015 Aug; 80(8):1001-9. PubMed ID: 26547068
[TBL] [Abstract][Full Text] [Related]
17. MiR-146a down-regulates inflammatory response by targeting TLR3 and TRAF6 in Coxsackievirus B infection.
Fei Y; Chaulagain A; Wang T; Chen Y; Liu J; Yi M; Wang Y; Huang Y; Lin L; Chen S; Xu W; Tong L; Wu X; Zhao D; Zhang F; Zhao W; Zhong Z
RNA; 2020 Jan; 26(1):91-100. PubMed ID: 31676570
[TBL] [Abstract][Full Text] [Related]
18. MiR-223/Pknox1 axis protects mice from CVB3-induced viral myocarditis by modulating macrophage polarization.
Gou W; Zhang Z; Yang C; Li Y
Exp Cell Res; 2018 May; 366(1):41-48. PubMed ID: 29524390
[TBL] [Abstract][Full Text] [Related]
19. 5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.
Kim KS; Tracy S; Tapprich W; Bailey J; Lee CK; Kim K; Barry WH; Chapman NM
J Virol; 2005 Jun; 79(11):7024-41. PubMed ID: 15890942
[TBL] [Abstract][Full Text] [Related]
20. NOD2 (Nucleotide-Binding Oligomerization Domain 2) Is a Major Pathogenic Mediator of Coxsackievirus B3-Induced Myocarditis.
Tschöpe C; Müller I; Xia Y; Savvatis K; Pappritz K; Pinkert S; Lassner D; Heimesaat MM; Spillmann F; Miteva K; Bereswill S; Schultheiss HP; Fechner H; Pieske B; Kühl U; Van Linthout S
Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
